Dihydroxyacetone phosphate
|
Basic information |
| Metabolite name | Dihydroxyacetone phosphate |
 | HMDB0001473 |
 |
C00111 |
 |
668 |
| Synonyms | dihydroxy-acetone-phosphate |
| No. of studies | 13 |
|
Basic information |
| Metabolite name | Dihydroxyacetone phosphate |
| HMDB0001473 |
|
C00111 |
|
668 |
| Synonyms | dihydroxy-acetone-phosphate |
| No. of studies | 13 |
|
Relationship between Dihydroxyacetone phosphate and depression (count: 13) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M033 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Up |
| Study M050 | Type3 | 14h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Down |
| Study M060 | Type1 | training set: depressed group vs. control group | Peripheral blood mononuclear cell | Human | Up |
| Study M060 | Type1 | test set: depressed group vs. control group | Peripheral blood mononuclear cell | Human | Down |
| Study M062 | Type1 | CUMS group vs. control group | Cerebellum | Sprague-Dawley rat | Down |
| Study M096 | Type1 | CUMS group vs. control group | Hippocampus | Wistar rat | Down |
| Study M096 | Type2 | CUMS + paroxetine group vs. CUMS group | Hippocampus | Wistar rat | Up |
| Study M555 | Type1 | FMT group vs. control group | Liver | Sprague-Dawley rat | Up |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Serum | C57BL/6 J mouse | Up |
| Study M664 | Type1 | CSDS group vs. control group | Hippocampus | C57BL/6 J mouse | Up |
| Study M671 | Type1 | CUMS group vs. control group | Striatum | Sprague-Dawley rat | Down |
| Study M762 | Type1 | corticosterone group vs. control group | Liver | Wistar rat | Down |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Down |
| Study M883 | Type1 | MDD group vs. control group | Blood | Human | Up |
| Study M948 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |